Edition:
United Kingdom

People: argenx SE (ARGX.BR)

ARGX.BR on Brussels Stock Exchange

112.70EUR
13 Sep 2019
Change (% chg)

-- (--)
Prev Close
€112.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
93,668
52-wk High
€135.70
52-wk Low
€54.30

McLeod, Rebecca 

Ms. Rebecca McLeod serves as Vice President Marketing at argenx SE. She has almost 20 years as a proven biopharmaceutical leader. Prior to joining argenx, she was most recently Executive Director, Sales at Alexion Pharmaceuticals. Prior to this she was the Head of Alexion US Marketing for atypical hemolytic uremic syndrome (aHUS), leading strategic vision and tactical implementation for the company’s largest revenue generating market. Earlier in her career, she held positions of increasing responsibility in sales and marketing roles with Takeda Pharmaceuticals North America. Ms. Rebecca Rupert has a Master’s of Business Administration, Marketing from The University of Arkansas, Little Rock and a Bachelor of Business Administration with a focus on marketing from the University of Mississippi.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --